Search - tctmd.com

Displaying 101 - 120 of 183

Sort: Relevancy | Date

Presentation CHIP Seattle 2017

The Hemodynamics of Cardiogenic Shock: Lessons Learned from the TEACH Initiative

Presenter: Daniel Burkhoff

August 11, 2017

Presentation CHIP Seattle 2017

What Defines a Shock Center and When to Transfer

Presenter: Claudius Mahr

August 11, 2017

Presentation CHIP Seattle 2017

Inotropes and Drug Therapies for Shock: Data and Outcomes

Presenter: Sunil V. Rao

August 11, 2017

Presentation

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

August 07, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

Presentation SOLACI 2017

Prevention of Valvular Thrombosis: Antiaggregation or Anticoagulation?

Presenter: Fernando Pineda

August 02, 2017

Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

Presentation ACC 2017

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Presenter: Stephen J Nicholls

March 20, 2017

Presentation ACC 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Presenter: Jeff Weitz

March 20, 2017

Presentation ACC 2017

EBBINGHAUS: A Cognitive Study of Patients Enrolled in the FOURIER Trial

Presenter: Robert Giugliano

March 19, 2017

Presentation ACC 2017

ORION-1: Primary Efficacy & Safety Outcomes

Presenter: Kausik K. Ray

March 17, 2017

Presentation ACC 2017

Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk

Presenter: Marc Sabatine

March 17, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation AHA 2016

GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound

Presenter: Steven E. Nissen

November 15, 2016

Presentation Cardiovascular Interventions 2016

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Presenter: Dean J. Kereiakes

November 10, 2016

Presentation

Antiplatelet Therapy and Outcomes in Patients Undergoing Surgery After Stenting

Presenter: Roberta Rossini

July 18, 2016

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation SOLACI 2016

Adjunctive Pharmacology for Patients with ACS Treated Invasively

Presenter: Eric R. Bates

June 09, 2016

Presentation

Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses

Presenter: Haris Riaz

May 11, 2016

Advertisement

The Hemodynamics of Cardiogenic Shock: Lessons Learned from the TEACH Initiative

What Defines a Shock Center and When to Transfer

Inotropes and Drug Therapies for Shock: Data and Outcomes

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Prevention of Valvular Thrombosis: Antiaggregation or Anticoagulation?

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

EBBINGHAUS: A Cognitive Study of Patients Enrolled in the FOURIER Trial

ORION-1: Primary Efficacy & Safety Outcomes

Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Antiplatelet Therapy and Outcomes in Patients Undergoing Surgery After Stenting

Optimal Duration of DAPT: Update on DAPT Guidelines

Adjunctive Pharmacology for Patients with ACS Treated Invasively

Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content